Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The aim of the randomized double blind trial with 134 patients presenting old world cutaneous
leishmaniasis is:
- to evaluate the clinical efficacy of electro-thermo-cauterisation (ETC) followed by
moist wound treatment versus ETC followed by moist wound treatment plus 0.05 %
pharmaceutical chlorite that has been used in three European countries (Germany, Austria
and Switzerland) in wound care management for more than 20 years;
- to judge whether early wound care management would present a viable improvement to the
actual anti-parasitic treatments mostly neglecting the chronic wound problem and to
evaluate its long-term effect on immunity through relapse control 6 months after wound
healing.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Waisenmedizin e. V. Promoting Access to Essential Medicine
Collaborators:
German Medical Service (GMS) in Kabul German Medical Service Kabul GMS non-profit Afghan NGO Microbiology Institute Clinical Microbiology Immunology and Hygiene University Clinic of Erlangen Germany University of Freiburg Waisenmedzin eV PACEM non-profit German NGO